Regencell Bioscience (RGC) has had the highest return since May 24, 2021 by a mid-cap US stock, returning 5,276.8%.
Regencell Bioscience (RGC) has had the highest return since May 24, 2021 by a mid-cap US stock, returning 5,276.8%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.